Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Systemic sclerosis
•
Scleroderma
•
Neurology
•
Ophthalmology
•
Neuro-Ophthalmology
How would you approach management of a patient with systemic sclerosis and optic perineuritis?
No other cause of optic perineuritis identified.
Related Questions
How do you counsel patients with GCA on the benefits of steroids who have already experienced vision loss?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
How do you approach the significance of +RNP III antibody in a patient with positive ANA but no other signs or symptoms of systemic sclerosis?
When do you use GLP-1 receptor agonists for the management of patients with idiopathic intracranial hypertension (IIH)?
How do you approach initial steroid dosing in patients with eosinophilic fasciitis?
What is the clinical significance of an isolated anti-centromere B antibody in a patient with pulmonary fibrosis but no other features of systemic sclerosis?
What brain imaging findings do you find reliable to help support a diagnosis of idiopathic intracranial hypertension?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How do you approach management of a patient presenting with clinical manifestations of systemic sclerosis (cutaneous involvement, Raynaud’s phenomenon, and pulmonary arterial hypertension) but negative serologies?
How do you approach diagnosis and management of orbital myositis?